Lineage restriction of the RARalpha gene expression in myeloid differentiation.
Heyworth, Clare M
AffiliationLeukaemia Research Fund Centre and Section of Gene Function and Regulation at the Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom.
MetadataShow full item record
AbstractTo better understand the role of retinoids in myelopoiesis, expression of the retinoid receptor genes (retinoic acid receptors [RARs] and retinoid X receptors [RXRs]) were examined during differentiation of factor-dependent cell-Paterson (FDCP)-mixA4 murine progenitor cells. The major receptor expressed in undifferentiated A4 cells was RARalpha (primarily the RARalpha1 isoform). Following induction of myelomonocytic differentiation with granulocyte and granulocyte-macrophage colony-stimulating factors, a dramatic increase in RARalpha expression (particularly the RARalpha2 isoform) was seen. In contrast, expression of both RARalpha isoforms was rapidly extinguished upon induction of erythroid differentiation with erythropoeitin (EPO). A modest induction of RXRalpha expression was seen, particularly during differentiation in the myelomonocytic lineage. Low expression levels of RARgamma2 and RXRbeta remained unchanged, irrespective of differentiation pathway. Consistent with the gene expression patterns, RARalpha agonists and antagonists stimulated myelomonocytic and erythroid differentiation of FDCP-mixA4 cells, respectively. Taken together, these results suggest that erythropoiesis and granulopoiesis require diminished and enhanced RARalpha activities, respectively, which at physiological all-trans-retinoic acid (RA) concentrations may be accomplished by reciprocal effects of EPO and myelomonocytic growth factors on its expression. This hypothesis is corroborated by data showing that RA, which positively regulates RARalpha2 expression, can exert inhibitory effects on erythroid differentiation.
CitationLineage restriction of the RARalpha gene expression in myeloid differentiation. 2001, 98 (8):2563-7 Blood
- Retinoic acid induces apoptosis of human CD34+ hematopoietic progenitor cells: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells.
- Authors: Josefsen D, Blomhoff HK, Lømo J, Blystad AK, Smeland EB
- Issue date: 1999 Apr
- Transgenic expression of PML/RARalpha impairs myelopoiesis.
- Authors: Early E, Moore MA, Kakizuka A, Nason-Burchenal K, Martin P, Evans RM, Dmitrovsky E
- Issue date: 1996 Jul 23
- Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways.
- Authors: Glasow A, Prodromou N, Xu K, von Lindern M, Zelent A
- Issue date: 2005 Jan 1
- Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma.
- Authors: Labrecque J, Allan D, Chambon P, Iscove NN, Lohnes D, Hoang T
- Issue date: 1998 Jul 15
- The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells.
- Authors: Rusten LS, Dybedal I, Blomhoff HK, Blomhoff R, Smeland EB, Jacobsen SE
- Issue date: 1996 Mar 1